Even today, almost a century after the discovery of insulin, the most common cause of death in a child with diabetes from a global perspective is lack of access to insulin. Many children die before their diabetes is diagnosed. It is therefore of utmost importance that all forces unite to ensure that no child should die from diabetes.
The International Society for Pediatric and Adolescent Diabetes (ISPAD) published its first set of guidelines in 1995 and its second in 2000. Since then, the acceptance of intensive therapy, also for very young children, has increased around the world. Insulin pump usage has risen in all age groups in countries where this treatment modality can be afforded. Intensive therapy requires better and more comprehensive education for it to be successful.
The current guideline has been developed by ISPAD and the International Diabetes Federation. While there is extensive evidence on the optimal management of type 1 diabetes, unfortunately such care is not reaching many people who could benefit.